Insulet Corporation
PODD Real Time Price USD$PODD is featured in our Tina Smith strategy.
All StrategiesRecent trades of PODD by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes in PODD holdings by institutional investors
Quarterly net insider trading by PODD's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$110,000 Oct 17, 2025 Issue: Health Issues
-
$130,000 Jul 21, 2025 Issue: Health Issues
-
$40,000 Apr 17, 2025 Issue: Health Issues
-
$90,000 Jan 20, 2025 Issue: Health Issues
-
$50,000 Oct 18, 2024 Issue: Health Issues
-
$160,000 Jul 19, 2024 Issue: Health Issues
-
$70,000 Apr 22, 2024 Issue: Health Issues
-
$60,000 Jan 19, 2024 Issue: Health Issues
-
$100,000 Oct 20, 2023 Issue: Health Issues
-
$60,000 Jul 18, 2023 Issue: Health Issues
-
$50,000 Jan 19, 2023 Issue: Health Issues
-
$50,000 Oct 14, 2022 Issue: Health Issues
-
$50,000 Jul 18, 2022 Issue: Health Issues
-
$40,000 Apr 18, 2022 Issue: Health Issues
-
$10,000 Jan 20, 2022 Issue: Health Issues
-
$10,000 Apr 19, 2018 Issue: Health Issues Medicare/Medicaid
-
$50,000 Apr 09, 2018 Issue: Health Issues
-
$40,000 Jan 19, 2018 Issue: Health Issues Medicare/Medicaid
-
$140,000 Jan 18, 2018 Issue: Medicare/Medicaid
-
$15,000 Jan 16, 2018 Issue: Health Issues
-
$60,000 Oct 18, 2017 Issue: Health Issues Medicare/Medicaid
-
$140,000 Oct 17, 2017 Issue: Medicare/Medicaid
-
$120,000 Jul 21, 2017 Issue: Medicare/Medicaid
-
$40,000 Jul 19, 2017 Issue: Health Issues Medicare/Medicaid
-
$90,000 Apr 24, 2017 Issue: Medicare/Medicaid
-
$20,000 Apr 20, 2017 Issue: Health Issues Medicare/Medicaid
-
$90,000 Jan 19, 2017 Issue: Medicare/Medicaid
-
$60,000 Oct 14, 2016 Issue: Medicare/Medicaid
-
$40,000 Jul 19, 2016 Issue: Medicare/Medicaid
-
$40,000 Apr 20, 2016 Issue: Medicare/Medicaid
-
$50,000 Jan 20, 2016 Issue: Medicare/Medicaid
-
$50,000 Oct 20, 2015 Issue: Medicare/Medicaid
-
$35,000 Jul 29, 2015 Issue: Medicare/Medicaid
-
$30,000 Jul 20, 2015 Issue: Medicare/Medicaid
-
$35,000 Jan 20, 2015 Issue: Medicare/Medicaid
-
$20,000 Oct 16, 2014 Issue: Medicare/Medicaid
-
$30,000 Jul 17, 2014 Issue: Medicare/Medicaid
-
$20,000 Apr 11, 2014 Issue: Medicare/Medicaid
-
$20,000 Jan 16, 2014 Issue: Medicare/Medicaid
-
$30,000 Oct 18, 2013 Issue: Medicare/Medicaid
-
$40,000 Jul 19, 2013 Issue: Medicare/Medicaid
-
$10,000 Jan 22, 2013 Issue: Medicare/Medicaid
-
$40,000 Oct 22, 2012 Issue: Medicare/Medicaid
-
$30,000 Jan 20, 2012 Issue: Health Issues
-
$30,000 Oct 20, 2011 Issue: Health Issues
-
$30,000 Jul 20, 2011 Issue: Health Issues
-
$30,000 Apr 25, 2011 Issue: Health Issues
-
$30,000 Jan 20, 2011 Issue: Health Issues
-
$30,000 Oct 21, 2010 Issue: Health Issues
PODD Estimated quarterly lobbying spending
PODD Revenue by Segment or Geography
New PODD patent grants
-
Patent Title: Activity mode for artificial pancreas system Oct. 07, 2025
-
Patent Title: Adhesive pad with a metallic coil for securing an on-body medical device Oct. 07, 2025
-
Patent Title: Medicament delivery device with an adjustable and piecewise analyte level cost component to address persistent positive analyte level excursions Sep. 30, 2025
-
Patent Title: Low force valves for drug delivery pumps Sep. 30, 2025
-
Patent Title: User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system Sep. 30, 2025
-
Patent Title: Drug delivery device with indicator Sep. 23, 2025
-
Patent Title: Optimizing embedded formulations for drug delivery Sep. 09, 2025
-
Patent Title: Exercise safety prediction based on physiological conditions Sep. 02, 2025
-
Patent Title: Infusion pump assembly and method Sep. 02, 2025
-
Patent Title: Operating a portable medical device Sep. 02, 2025
-
Patent Title: Insulin delivery system and methods with risk-based set points Aug. 12, 2025
-
Patent Title: Single actuated precision dose intermediate pumping chamber Aug. 05, 2025
-
Patent Title: Adaptive update of automatic insulin delivery (aid) control parameters Jul. 29, 2025
-
Patent Title: Use of fuzzy logic in predicting user behavior affecting blood glucose concentration in a closed loop control system of an automated insulin delivery device Jul. 29, 2025
-
Patent Title: Spring-based status sensors Jul. 15, 2025
-
Patent Title: System and method for adjusting insulin delivery Jul. 01, 2025
-
Patent Title: Techniques to reduce risk of occlusions in drug delivery systems Jul. 01, 2025
-
Patent Title: Fluid delivery device, transcutaneous access tool and fluid drive mechanism for use therewith Jun. 17, 2025
-
Patent Title: Micro piston pump Jun. 03, 2025
-
Patent Title: On-body interlock for drug delivery device Jun. 03, 2025
-
Patent Title: System and method for adjusting insulin delivery Jun. 03, 2025
-
Patent Title: Automated drug delivery device May. 20, 2025
-
Patent Title: Automated drug delivery device Apr. 23, 2024
-
Patent Title: Display screen with a graphical user interface Jan. 09, 2024
-
Patent Title: Display screen with a graphical user interface Dec. 12, 2023
-
Patent Title: Display screen with graphical user interface Feb. 07, 2023
-
Patent Title: Overlay for drug delivery device Nov. 29, 2022
-
Patent Title: Display screen with a graphical user interface Jan. 04, 2022
-
Patent Title: Drug delivery device Feb. 25, 2020
-
Patent Title: Display screen with a graphical user interface Feb. 04, 2020
-
Patent Title: Display screen with a graphical user interface Jan. 14, 2020
-
Patent Title: Display screen with a graphical user interface Jan. 14, 2020
-
Patent Title: Display screen with a graphical user interface Dec. 10, 2019
-
Patent Title: Display screen with graphical user interface Dec. 10, 2019
-
Patent Title: Drug delivery device Nov. 05, 2019
-
Patent Title: Display screen with a graphical user interface Oct. 08, 2019
-
Patent Title: Drug delivery device Jun. 18, 2019
-
Patent Title: Display screen with a graphical user interface Jun. 18, 2019
-
Patent Title: Display screen with a graphical user interface Jan. 29, 2019
-
Patent Title: Display screen with a graphical user interface Jan. 22, 2019
-
Patent Title: Drug delivery device Dec. 25, 2018
-
Patent Title: Display screen with a graphical user interface Dec. 18, 2018
-
Patent Title: Display screen with a graphical user interface Aug. 28, 2018
-
Patent Title: Display screen with a graphical user interface Aug. 28, 2018
-
Patent Title: Fluid delivery device, transcutaneous access tool and fluid drive mechanism for use therewith Aug. 02, 2016
-
Patent Title: Calculating insulin on board for an extended bolus being delivered by an insulin delivery device Jun. 18, 2013
-
Patent Title: Calculating insulin on board for extended bolus being delivered by an insulin delivery device Mar. 20, 2012
-
Patent Title: Interfacing a prefilled syringe with an infusion pump to fill the infusion pump Apr. 05, 2011
-
Patent Title: Flow condition sensor assembly for patient infusion device Feb. 15, 2011
-
Patent Title: Environmental seal for fluid delivery device Aug. 10, 2010
Federal grants, loans, and purchases
Estimated quarterly amount awarded to PODD from public contracts
Recent insights relating to PODD
Recent picks made for PODD stock on CNBC
ETFs with the largest estimated holdings in PODD
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $PODD stock a Buy, Sell, or Hold?
- What is the price target for $PODD stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $PODD stock?
- Who owns the most shares of $PODD stock?
- What funds own $PODD stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view PODD Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.
- Address Acton, MA
- Market Cap 23.4 billion
- Employees 3,900
- Industrial Classification Surgical & Medical Instruments & Apparatus